Oral miltefosine to treat new world cutaneous leishmaniasis.
Soto
Jaime
J
Toledo
Julia T
JT
D000284:Administration, Oral; D000818:Animals; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007892:Leishmania braziliensis / Q000187:drug effects; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy*; D010767:Phosphorylcholine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000981:Antiprotozoal Agents; D010767:Phosphorylcholine; C039128:miltefosine